Defective Suppressor Function of Human CD4+ CD25+ Regulatory T Cells in Autoimmune Polyglandular Syndrome Type II

Journal of Experimental Medicine

Volumn 199, Issue 9, 2004, Pages 1285-1291

  Kriegel, Martin A ^a,b   Lohmann, Tobias ^a   Gabler, Christoph ^a   Blank, Norbert ^a   Kalden, Joachim R ^a   Lorenz, Hanns Martin ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addison's disease; Autoimmune polyendocrinopathies; Autoimmune thyroiditis; Suppressor cells; Type I diabetes

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ADDISON DISEASE; ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE 2; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE DISEASE; FEMALE; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; MALE; PATHOGENESIS; PRIORITY JOURNAL; SUPPRESSOR CELL; SYNDROME DELINEATION; T LYMPHOCYTE SUBPOPULATION;

ADDISON DISEASE; ADULT; AGED; ANTIGENS, CD; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYENDOCRINOPATHIES, AUTOIMMUNE; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES; THYROIDITIS, AUTOIMMUNE;

EID: 2442628376     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20032158     Document Type: Article

References (29)

1. Walker, L.S., and A.K. Abbas. 2002. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2:11-19.
2. Shevach, E.M. 2002. CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389-400.
3. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198:235-247.
4. + T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197:111-119.
5. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193:1295-1302.
6. Fontenot, J.D., M.A. Gavin, and A.Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat. Immunol. 4:330-336.
7. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057-1061.
8. Khattri, R., T. Cox, S.A. Yasayko, and F. Ramsdell. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4:337-342.
9. Bennett, C.L., J. Christie, F. Ramsdell, M.E. Brunkow, P.J. Ferguson, L. Whitesell, T.E. Kelly, F.T. Saulsbury, P.F. Chance, and H.D. Ochs. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:20-21.
10. + regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J. Exp. Med. 196: 247-253.
11. + T cells with regulatory properties from human blood. J. Exp. Med. 193:1303-1310.
12. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193:1285-1294.
13. + T helper cells. J. Exp. Med. 196:255-260.
14. Taams, L.S., J. Smith, M.H. Rustin, M. Salmon, L.W. Poulter, and A.N. Akbar. 2001. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 31:1122-1131.
15. Baecher-Allan, C., J.A. Brown, G.J. Freeman, and D.A. Hafler. 2001. Cd4(+)cd25(high) regulatory cells in human peripheral blood. J. Immunol. 167:1245-1253.
16. + human thymocytes. J. Exp. Med. 196:379-387.
17. Sakaguchi, S., N. Sakaguchi, J. Shimizu, S. Yamazaki, T. Sakihama, M. Itoh, Y. Kuniyasu, T. Nomura, M. Toda, and T. Takahashi. 2001. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182:18-32.
18. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164.
19. Devendra, D., and G.S. Eisenbarth. 2003. 17. Immunologic endocrine disorders. J. Allergy Clin. Immunol. 111:S624-S636.
20. Anderson, M.S. 2002. Autoimmune endocrine disease. Curr. Opin. Immunol. 14:760-764.
21. Anderson, M.S., E.S. Venanzi, L. Klein, Z. Chen, S.P. Berzins, S.J. Turley, H. von Boehmer, R. Bronson, A. Dierich, C. Benoist, and D. Mathis. 2002. Projection of an immunological self shadow within the thymus by the aire protein. Science. 298:1395-1401.
22. Wallaschofski, H., A. Meyer, U. Tuschy, and T. Lohmann. 2003. HLA-DQA1*0301-associated susceptibility for autoimmune polyglandular syndrome type II and III. Horm. Metab. Res. 35:120-124.
23. Blank, N., M. Kriegel, T. Hieronymus, T. Geiler, S. Winkler, J.R. Kalden, and H.M. Lorenz. 2001. CD45 tyrosine phosphatase controls common gamma-chain cytokine-mediated STAT and extracellular signal-related kinase phosphorylation in activated human lymphoblasts: inhibition of proliferation without induction of apoptosis. J. Immunol. 166: 6034-6040.
24. Pasare, C., and R. Medzhitov. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science. 299:1033-1036.
25. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194:629-644.
26. McHugh, R.S., M.J. Whitters, C.A. Piccirillo, D.A. Young, E.M. Shevach, M. Collins, and M.C. Byrne. 2002. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 16:311-323.
27. Shimizu, J., S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi. 2002. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3:135-142.
28. LaSalle, J.M., P.J. Tolentino, G.J. Freeman, L.M. Nadler, and D.A. Hafler. 1992. Early signaling defects in human T cells anergized by T cell presentation of autoantigen. J. Exp. Med. 176:177-186.
29. Herold, K.C., W. Hagopian, J.A. Auger, E. Poumian-Ruiz, L. Taylor, D. Donaldson, S.E. Gitelman, D.M. Harlan, D. Xu, R.A. Zivin, and J.A. Bluestone. 2002. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346:1692-1698.